Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis

Panagiotis I. Georgianos, Rajiv Agarwal

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

The diagnosis and management of hypertension among patients on chronic dialysis is challenging. Routine peridialytic blood pressure recordings are unable to accurately diagnose hypertension and stratify cardiovascular risk. By contrast, blood pressure recordings taken outside the dialysis setting exhibit clear prognostic associations with survival and might facilitate the diagnosis and long-term management of hypertension. Once accurately diagnosed, management of hypertension in individuals on chronic dialysis should initially involve non-pharmacological strategies to control volume overload. Accordingly, first-line strategies should focus on achieving dry weight, individualizing dialysate sodium concentrations and ensuring dialysis sessions are at least 4 h in duration. If blood pressure remains unresponsive to volume management strategies, pharmacological treatment is required. The choice of appropriate antihypertensive regimen should be individualized taking into account the efficacy, safety, and pharmacokinetic properties of the antihypertensive medications as well as any comorbid conditions and the overall risk profile of the patient. In contrast to their effects in the general hypertensive population, emerging evidence suggests that β-blockers might offer the greatest cardioprotection in hypertensive patients on dialysis. In this Review, we discuss estimates of the epidemiology of hypertension in the dialysis population as well as the challenges in diagnosing and managing hypertension among these patients.

Original languageEnglish (US)
Pages (from-to)636-647
Number of pages12
JournalNature Reviews Nephrology
Volume12
Issue number10
DOIs
StatePublished - Oct 1 2016

Fingerprint

Dialysis
Epidemiology
Hypertension
Blood Pressure
Antihypertensive Agents
Dialysis Solutions
Population
Pharmacokinetics
Sodium
Pharmacology
Safety
Weights and Measures
Survival
Therapeutics

ASJC Scopus subject areas

  • Nephrology

Cite this

Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis. / Georgianos, Panagiotis I.; Agarwal, Rajiv.

In: Nature Reviews Nephrology, Vol. 12, No. 10, 01.10.2016, p. 636-647.

Research output: Contribution to journalReview article

@article{9313cb4583714e9fb5905196c2dd8d80,
title = "Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis",
abstract = "The diagnosis and management of hypertension among patients on chronic dialysis is challenging. Routine peridialytic blood pressure recordings are unable to accurately diagnose hypertension and stratify cardiovascular risk. By contrast, blood pressure recordings taken outside the dialysis setting exhibit clear prognostic associations with survival and might facilitate the diagnosis and long-term management of hypertension. Once accurately diagnosed, management of hypertension in individuals on chronic dialysis should initially involve non-pharmacological strategies to control volume overload. Accordingly, first-line strategies should focus on achieving dry weight, individualizing dialysate sodium concentrations and ensuring dialysis sessions are at least 4 h in duration. If blood pressure remains unresponsive to volume management strategies, pharmacological treatment is required. The choice of appropriate antihypertensive regimen should be individualized taking into account the efficacy, safety, and pharmacokinetic properties of the antihypertensive medications as well as any comorbid conditions and the overall risk profile of the patient. In contrast to their effects in the general hypertensive population, emerging evidence suggests that β-blockers might offer the greatest cardioprotection in hypertensive patients on dialysis. In this Review, we discuss estimates of the epidemiology of hypertension in the dialysis population as well as the challenges in diagnosing and managing hypertension among these patients.",
author = "Georgianos, {Panagiotis I.} and Rajiv Agarwal",
year = "2016",
month = "10",
day = "1",
doi = "10.1038/nrneph.2016.129",
language = "English (US)",
volume = "12",
pages = "636--647",
journal = "Nature Reviews Nephrology",
issn = "1759-507X",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis

AU - Georgianos, Panagiotis I.

AU - Agarwal, Rajiv

PY - 2016/10/1

Y1 - 2016/10/1

N2 - The diagnosis and management of hypertension among patients on chronic dialysis is challenging. Routine peridialytic blood pressure recordings are unable to accurately diagnose hypertension and stratify cardiovascular risk. By contrast, blood pressure recordings taken outside the dialysis setting exhibit clear prognostic associations with survival and might facilitate the diagnosis and long-term management of hypertension. Once accurately diagnosed, management of hypertension in individuals on chronic dialysis should initially involve non-pharmacological strategies to control volume overload. Accordingly, first-line strategies should focus on achieving dry weight, individualizing dialysate sodium concentrations and ensuring dialysis sessions are at least 4 h in duration. If blood pressure remains unresponsive to volume management strategies, pharmacological treatment is required. The choice of appropriate antihypertensive regimen should be individualized taking into account the efficacy, safety, and pharmacokinetic properties of the antihypertensive medications as well as any comorbid conditions and the overall risk profile of the patient. In contrast to their effects in the general hypertensive population, emerging evidence suggests that β-blockers might offer the greatest cardioprotection in hypertensive patients on dialysis. In this Review, we discuss estimates of the epidemiology of hypertension in the dialysis population as well as the challenges in diagnosing and managing hypertension among these patients.

AB - The diagnosis and management of hypertension among patients on chronic dialysis is challenging. Routine peridialytic blood pressure recordings are unable to accurately diagnose hypertension and stratify cardiovascular risk. By contrast, blood pressure recordings taken outside the dialysis setting exhibit clear prognostic associations with survival and might facilitate the diagnosis and long-term management of hypertension. Once accurately diagnosed, management of hypertension in individuals on chronic dialysis should initially involve non-pharmacological strategies to control volume overload. Accordingly, first-line strategies should focus on achieving dry weight, individualizing dialysate sodium concentrations and ensuring dialysis sessions are at least 4 h in duration. If blood pressure remains unresponsive to volume management strategies, pharmacological treatment is required. The choice of appropriate antihypertensive regimen should be individualized taking into account the efficacy, safety, and pharmacokinetic properties of the antihypertensive medications as well as any comorbid conditions and the overall risk profile of the patient. In contrast to their effects in the general hypertensive population, emerging evidence suggests that β-blockers might offer the greatest cardioprotection in hypertensive patients on dialysis. In this Review, we discuss estimates of the epidemiology of hypertension in the dialysis population as well as the challenges in diagnosing and managing hypertension among these patients.

UR - http://www.scopus.com/inward/record.url?scp=84984656685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984656685&partnerID=8YFLogxK

U2 - 10.1038/nrneph.2016.129

DO - 10.1038/nrneph.2016.129

M3 - Review article

C2 - 27573731

AN - SCOPUS:84984656685

VL - 12

SP - 636

EP - 647

JO - Nature Reviews Nephrology

JF - Nature Reviews Nephrology

SN - 1759-507X

IS - 10

ER -